Shortage pharmaceuticals: various pharmaceutical shortage items; including, but not limited to, blood products such as: carimune; oncological pharmaceuticals such as: vinblastine, novoseven and…
Ended Awarded
- Contract number
- HT001419F0016
- Awardee
-
The Compounding Center Inc. UEI J69ERCPB7369
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $300,000
Award facts
- Contract value 100% obligated
- $300,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621111 Offices of Physicians (except Mental Health Specialists)
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a firm fixed price contract to The Compounding Center Inc., a minority-owned and self-certified small disadvantaged business, to provide various shortage pharmaceutical items including blood products, oncological pharmaceuticals, injectables, orals, and inhalations. The $300,000.00 contract is a Blanket Purchase Agreement (BPA) Call with a performance period ending September 30, 2019. The Compounding Center, a for-profit Subchapter S corporation, has also received over $700,000 in prior purchase orders from the Department of Health and Human Services and Defense Health Agency to supply pharmaceuticals, vaccines, and shortage drugs for military and civilian treatment facilities, primarily in the Bethesda, Maryland area. This contract does not have a set-aside designation.
Description
Shortage pharmaceuticals: various pharmaceutical shortage items; including, but not limited to, blood products such as: carimune; oncological pharmaceuticals such as: vinblastine, novoseven and other relevant pharmaceuticals products including injectables, orals and medicinal inhalations.
Quick answers
Who was awarded contract HT001419F0016?
HT001419F0016 was awarded to The Compounding Center Inc. by Defense Health Agency (Department of Defense) on November 13, 2018.
How much is contract HT001419F0016 worth?
The government has obligated $300,000 on HT001419F0016.
Is contract HT001419F0016 an order under another contract?
Yes. HT001419F0016 is a BPA call under HT001415A0024, a blanket purchase agreement.
Was contract HT001419F0016 competed?
The extent of competition for HT001419F0016 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award